Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biogen Pharmachem Industries has informed that a meeting of the Board of Directors of the Company will be held on Tuesday 18th May, 2021 at Rajkot, Gujarat to consider following business: Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2021 and any other matter which the Board may think fit.
he above information is a part of company’s filings submitted to BSE.
